Wall Street Beat
Private equity shops battle for Philips’ legacy lighting biz
Bayer aims to boost drugs sales, margins over next 3 years
Diabetes: Valeritas sets terms for $75m IPO
Valeritas yesterday set the terms for its forthcoming initial public offering, saying it plans to put up 5 million shares at $14 to $16 each.
At the midpoint of the range, the IPO would fetch $75 million for Bridgewater, N.J.-based Valeritas, which plans to list on the NASDAQ exchange under the "VLRX" symbol.
New Siemens healthcare unit to start in May
Australia halts trading in GI Dynamics shares
The Australian stock exchange today granted a request from GI Dynamics (ASX:GID) to halt trading in shares of its stock, pending a company announcement between now and March 9.